review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Rodgers RJ | |
P433 | issue | 6-7 | |
P304 | page(s) | 477-96; discussion 497-504 | |
P577 | publication date | 1997-11-01 | |
P1433 | published in | Behavioural Pharmacology | Q15754239 |
P1476 | title | Animal models of 'anxiety': where next? | |
P478 | volume | 8 |
Q28297569 | 50 years of hurdles and hope in anxiolytic drug discovery |
Q53820290 | A Novel Integrative Mechanism in Anxiolytic Behavior Induced by Galanin 2/Neuropeptide Y Y1 Receptor Interactions on Medial Paracapsular Intercalated Amygdala in Rats. |
Q34447083 | A comparison of chlordiazepoxide, bretazenil, L838,417 and zolpidem in a validated mouse Vogel conflict test |
Q36674787 | A history of chronic morphine exposure during adolescence increases despair-like behaviour and strain-dependently promotes sociability in abstinent adult mice |
Q44926592 | Alteration in plasma corticosterone levels following long term oral administration of lead produces depression like symptoms in rats |
Q36077324 | An Experimental Study to Evaluate the Effect of Memantine in Animal Models of Anxiety in Swiss Albino Mice |
Q35686014 | An Exploration Based Cognitive Bias Test for Mice: Effects of Handling Method and Stereotypic Behaviour. |
Q30471279 | Animal models of anxiety disorders in rats and mice: some conceptual issues |
Q36402320 | Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands. |
Q44914224 | Anxiolytic-like profile in Wistar, but not Sprague-Dawley rats in the social interaction test. |
Q44331106 | Atypical anxiolytic-like response to naloxone in benzodiazepine-resistant 129S2/SvHsd mice: role of opioid receptor subtypes |
Q40462255 | Behavioral evaluation of mice deficient in GABA(B(1)) receptor isoforms in tests of unconditioned anxiety. |
Q27349027 | Behavioral phenotype of maLPA1-null mice: increased anxiety-like behavior and spatial memory deficits |
Q46991223 | Cat odour-induced anxiety--a study of the involvement of the endocannabinoid system |
Q50915199 | Characteristics of extinction of a conditioned passive avoidance reflex in mice with different levels of anxiety. |
Q34434739 | Characterization of the nociceptin receptor (ORL-1) agonist, Ro64-6198, in tests of anxiety across multiple species |
Q37826637 | Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings |
Q36268050 | Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice |
Q36713301 | Context and strain-dependent behavioral response to stress |
Q39125935 | Critical neuropsychobiological analysis of panic attack- and anticipatory anxiety-like behaviors in rodents confronted with snakes in polygonal arenas and complex labyrinths: a comparison to the elevated plus- and T-maze behavioral tests |
Q34482680 | Effects of a post-shock injection of the kappa opioid receptor antagonist norbinaltorphimine (norBNI) on fear and anxiety in rats. |
Q34484556 | Evaluation of anxiolytic activity of compound Valeriana jatamansi Jones in mice |
Q35236855 | Experimental animal models for the simulation of depression and anxiety. |
Q48316346 | Free versus forced exposure to an elevated plus-maze: evidence for new behavioral interpretations during test and retest |
Q42944612 | GABA(A) ρ receptor mechanisms in the rat amygdala and its role in the modulation of fear and anxiety |
Q35104041 | Genetic animal models of anxiety |
Q48411622 | Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol |
Q30426914 | Housing conditions affect rat responses to two types of ambiguity in a reward-reward discrimination cognitive bias task |
Q35529375 | How animal models inform child and adolescent psychiatry |
Q30423940 | Impaired emotional learning and involvement of the corticotropin-releasing factor signaling system in patients with irritable bowel syndrome |
Q37286808 | Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats. |
Q47935068 | Measuring behavior of animal models: faults and remedies |
Q48664910 | Methylphenidate Causes Behavioral Impairments and Neuron and Astrocyte Loss in the Hippocampus of Juvenile Rats |
Q48389775 | Mice deficient in the alpha subunit of G(z) show changes in pre-pulse inhibition, anxiety and responses to 5-HT(1A) receptor stimulation, which are strongly dependent on the genetic background |
Q30488271 | Models and mechanisms of anxiety: evidence from startle studies |
Q34510367 | Molecular pathways of anxiety revealed by knockout mice |
Q47700367 | Neural mechanisms of placebo anxiolysis. |
Q33873442 | Neurons in the amygdala with response-selectivity for anxiety in two ethologically based tests |
Q38608639 | Nicotine Addiction and Psychiatric Disorders |
Q30372354 | Nicotine modulation of fear memories and anxiety: Implications for learning and anxiety disorders. |
Q46564664 | Noradrenaline transmission within the ventral bed nucleus of the stria terminalis is critical for fear behavior induced by trimethylthiazoline, a component of fox odor. |
Q30455336 | Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence |
Q35697254 | Ontogeny of fear-, anxiety- and depression-related behavior across adolescence in C57BL/6J mice |
Q33635704 | Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142. |
Q26749038 | Preclinical animal anxiety research - flaws and prejudices |
Q26770361 | Risk Evaluation of Endocrine-Disrupting Chemicals: Effects of Developmental Exposure to Low Doses of Bisphenol A on Behavior and Physiology in Mice (Mus musculus) |
Q48230748 | Scototaxis as anxiety-like behavior in fish. |
Q90277838 | Selective activation of serotoninergic dorsal raphe neurons facilitates sleep through anxiolysis |
Q36666353 | Sex-related effects of sleep deprivation on depressive- and anxiety-like behaviors in mice |
Q27342198 | Short and long term measures of anxiety exhibit opposite results |
Q44754270 | Social instability in female rats: effects on anxiety and buspirone efficacy |
Q27324635 | Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design. |
Q30427413 | Spontaneous behavior in noise and silence: a possible new measure to assess tinnitus in Guinea pigs. |
Q30478159 | Stability of inbred mouse strain differences in behavior and brain size between laboratories and across decades |
Q37146665 | Test- and behavior-specific genetic factors affect WKY hypoactivity in tests of emotionality. |
Q27305120 | The GABA(B) receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats |
Q30462832 | The age of anxiety: role of animal models of anxiolytic action in drug discovery |
Q34006734 | The anxiolytic effects of a Valerian extract is based on valerenic acid |
Q35910672 | The delayed effects of chronic unpredictable stress on anxiety measures |
Q34981207 | The effects of varied extinction procedures on contingent cue-induced reinstatement in Sprague-Dawley rats |
Q30454171 | The impact of anxiety upon cognition: perspectives from human threat of shock studies |
Q30448074 | The role of orphanin FQ/nociceptin in neuroplasticity: relationship to stress, anxiety and neuroinflammation |
Q30382078 | Trigeminal Inflammatory Compression (TIC) injury induces chronic facial pain and susceptibility to anxiety-related behaviors. |
Q75258769 | X-linked and lineage-dependent inheritance of coping responses to stress |
Search more.